Mayo Clinic Q&A podcast: A vaccine milestone

The Food and Drug Administration and Centers for Disease Control and Prevention have approved the first of several COVID-19 vaccines developed in response to the pandemic. The first vaccine has been distributed to all 50 states, and vaccinations are underway. Development of safe and effective COVID-19 vaccines has been an extraordinary effort of science and engineering.
"This is a milestone human achievement by any measure," says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group.
On the Mayo Clinic Q&A podcast, Dr. Poland discusses the rollout of COVID-19 vaccines in the U.S. and the timeline for vaccinations.
Dr. Poland has served as a consultant for Merck & Co. Inc., Medicago Inc., GlaxoSmithKline plc, Sanofi Pasteur, Emergent BioSolutions Inc., Dynavax Technologies Corp., Genentech Inc., Eli Lilly and Co., Kentucky BioProcessing Inc. and Genevant Sciences Corp., and Janssen Pharmaceuticals Inc. He is a paid scientific adviser for Johnson & Johnson. Honoraria: Elsevier.